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Abstract Improving quality of care in arthroplasty is of
increasing importance to payors, hospitals, surgeons, and
patients. Efforts to compel improvement have traditionally
focused measurement and reporting of data describing
structural factors, care processes (or ‘quality measures’),
and clinical outcomes. Reporting structural measures (eg,
surgical case volume) has been used with varying degrees
of success. Care process measures, exempliﬁed by initia-
tives such as the Surgical Care Improvement Project
measures, are chosen based on the strength of randomized
trial evidence linking the process to improved outcomes.
However, evidence linking improved performance on
Surgical Care Improvement Project measures with
improved outcomes is limited. Outcome measures in sur-
gery are of increasing importance as an approach to compel
care improvement with prominent examples represented
by the National Surgical Quality Improvement Project.
Although outcomes-focused approaches are often costly,
when linked to active benchmarking and collaborative
activities, they may improve care broadly. Moreover,
implementation of computerized data systems collecting
information formerly collected on paper only will facilitate
benchmarking. In the end, care will only be improved if
these data are used to deﬁne methods for innovating care
systems that deliver better outcomes at lower or equivalent
costs.
Introduction
Healthcare quality and safety improvement is a national
imperative with reports such as the Institute of Medicine’s
‘‘To Err Is Human’’ and ‘‘Crossing the Quality Chasm’’
providing the catalyst to compel broad system change. In
the nearly 8 years since these reports’ publication, a
number of national initiatives seek to measure care systems
so that care structures (eg, the sociologic or infrastructural
systems), care processes (eg, treatments provided to
patients), and our patient outcomes can be collected and
fairly compared across sites. These data can then be used
by caregivers to compel change within their site, by pur-
chasers seeking to choose preferred providers, by
regulators with the goal of accrediting hospitals, and by
patients making an informed choice about where to seek
care.
Understanding how to compare these elements of care—
structures, processes, and outcomes—across providers is of
importance in arthroplasty because total joint arthroplasty
is a highly common and costly procedure, one that is highly
effective at returning function and improving quality of
life. In this context, unexpected or unnecessary complica-
tions become even more egregious lapses in care.
We review an expanded version of a classic model for
assessing healthcare quality. We use the expanded
structure + process = outcome model to provide a
framework within which we review examples of struc-
ture-focused initiatives to improve care, process (or
quality-measure)-focused initiatives, and outcome-driven
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A Conceptual Model of Factors Associated
With Healthcare Outcomes
Donabedian ﬁrst proposed a highly useful model outlin-
ing factors contributing to patient outcomes in 1966
(Fig. 1)[ 10]. This model posits that care structures (such
as having a dedicated arthroplasty ward or care team)
and care processes (such as a standard arthroplasty care
pathway) can contribute to patient outcomes. Outcomes
can include patient-centered experiences, use of resour-
ces during the episode of care (such as costs), clinical
events such as mortality, major complications, readmis-
sion, functional status, pain, and ability to return to
work.
Understanding this model is relevant to health system
measurement in that it also provides the framework within
which one can identify and specify measures relevant to
one’s practice. In fact, many of these domains have been
the subject of national and regional initiatives that seek to
improve care by targeting one or more of the constituent
parts.
Structural Measurement as a Way to Compel Change
The Leapfrog Group [2] is a prominent example of a
healthcare system improvement initiative that, at least in its
early phases, primarily targeted care structures as a way to
compel change [2]. Founded in 1998 by a consortium of
large purchasers, the Leapfrog Group speciﬁed three major
structural measures in its early iterations: (1) adoption of
computerized physician order entry (CPOE); (2) use of
critical care board-certiﬁed physicians in intensive care
units; and (3) adherence to volume standards for selected
high-risk surgical procedures.
These measures were selected based in large part on the
evidence associating them with improved outcomes for
hospitalized patients. For example, volume measures for
high-risk surgery (which would imply that certain surgeries
would need to be regionalized) would result in a substantial
number of deaths being averted; adherence to all Leapfrog
measures would provide even more beneﬁts [2]. Structural
Structures of care  Processes of care  Outcomes 
  s e l p m a x E   s e l p m a x E   s e l p m a x E
• Presence of dedicated 
arthroplasty care team 
• Case volume of 
surgeons or hospital
• Presence of an 
arthroplasty care 
pathway
• Use of approved antimicrobials 
to prevent surgical site 
infections
• Type of implant used 
• Pain or range of 
motion
• Need for reoperation 
• Rates of surgical site 
infection
Fig. 1 The Donabedian model of
how healthcare system factors
can be used to measure care
quality, along with examples rel-
evant to arthroplasty, is shown
[11].
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123measures are also useful for practical reasons in that they
are usually easily collected and veriﬁable indicators. This
observation has led to the endorsement of case-volume as a
way for purchasers to identify preferred sites and improve
patient outcomes [4], an approach aptly termed ‘‘follow the
crowd’’ [2].
However well supported by evidence, many of the
initial Leapfrog measures have been extraordinarily dif-
ﬁcult to implement widely. Regionalization of services
poses practical problems [1] in that it is often very hard
for patients to travel long distances to seek a highest-
volume center or for surgeons to provide adequate post-
operative care for patients from far away. Volume
benchmarks’ ability to accurately identify ‘‘best’’ sites has
limitations [8, 9, 15, 19, 24]. Implementation of com-
puterized order entry is a resource- and time-intensive
process that may take years. Moreover, some volume
standards are increasingly hard to meet because of secular
changes in healthcare practice. Cardiac surgery volume
benchmarks, for example, are difﬁcult to meet as a result
of improved percutaneous coronary interventions such as
stenting [20].
Although we are focusing on the structural elements of
the Leapfrog model, it also includes a number of quality
and process measures derived in part from those recom-
mended from the National Quality Alliance and CMS Core
Measures. Adherence to Leapfrog measures is more likely
at larger hospitals and those participating in other quality
initiatives [11]. When adherence to Leapfrog measures is
maximal, mortality is lower in acute myocardial infarction
and in vascular surgery [6, 12].
Process Measures
The measurement and feedback of hospital (or surgeon)
performance on speciﬁc process measures is an alternative
approach to improving care. A key principle of process
measurement, whether as part of guidelines from profes-
sional societies or national reporting bodies [21], is that
they focus on care practices that should be followed
regardless of operative volume, site of care, or surgeon.
This aspect of processes means measurement of processes
also means that ‘‘optimal’’ patient groups for each process
must be deﬁned clearly. Within ‘‘optimal’’ patient groups,
care processes occur commonly, a feature that overcomes
the statistical shortcomings of focusing on rare events such
as mortality, potentially providing the ability to better
detect sites with poorer performance [3]. Finally, care
processes often represent clear elements of clinical practice
(such as administering a medication within a certain time
period) that are easily recognized as elements of everyday
work and which readily form teachable skills.
There are two notable examples of process-driven
quality initiatives: the Surgical Care Improvement Program
(SCIP) [23] and the Physicians Quality Reporting Initiative
(PQRI, www.cms.hhs.gov/pqri). SCIP arose from the Sur-
gical Infection Prevention program as a voluntary
collaborative and transitioned to a mandatory publicly
reported system in 2003. The incentive for participation in
SCIP was a Medicare payment withheld for nonparticipa-
tion that could be substantial depending on the size of the
facility. For patients undergoing joint arthroplasty, SCIP
measures represent a narrow but highly important set of
complications (surgical infection prevention and deep vein
thrombosis) with hospital-level performance measures
currently posted on www.hospitalcompare.org.
PQRI is a recent entry into the ﬁeld of process mea-
surement. PQRI was begun as part of the 2006 Tax Relief
and Health Care Act (PL 109-432), which required the
establishment of a physician quality reporting system. In
PQRI, physicians who report quality-measures data on
claims for services furnished to Medicare beneﬁciaries
January 1 through December 31, 2008 earn a single con-
solidated incentive payment of 1.5% of charges for covered
Physician Fee Schedule services sometime in 2009. The
PQRI speciﬁes more than 100 potential measures of qual-
ity, the majority of which represent care processes, but a
few of which (such as adoption of e-prescribing) are also
structural measures. PQRI incorporates the SCIP measures
as well as other measures potentially relevant to joint
arthroplasty such as treatment of osteoporosis after a
fracture, adequately addressing pain, and development of a
care plan in conjunction with the patient. PQRI differs
from SCIP in its expanded of list measures, a predominant
weighting of these measures toward outpatient/clinic care,
and the focus on individual physicians as the targets of the
feedback and incentives.
To date, there are few data to suggest that improvement
in process measure performance is associated with any
improvement in patient outcomes. Publicly reported pro-
cess measures for medical conditions such as acute
myocardial infarction, pneumonia, or congestive heart
failure have a modest association with reduced mortality
but explain only a small amount of mortality variation seen
across sites [5]. PQRI measures have not yet been studied,
but adherence to SCIP measures does not appear to be
associated with improved outcomes in general surgery; no
studies have examined the impact of SCIP measures in
orthopaedic surgery.
Process measures are increasingly also being seen as
ﬂawed for other reasons. First, pay-for-performance
focusing on processes appears to have a weak marginal
effect on improvements, particularly when most centers are
improving care [16]. Second, as adherence rates rise, they
will ‘‘ceiling’’ at 100%, making it difﬁcult to discern
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123high- from low-performing sites. Third, process measures
themselves may require risk adjustment to account for
subtle differences in patients, even those deﬁned as
‘‘optimal candidates’’ [17]. Fourth, ﬁnancial incentives
based on care processes tend to have weak marginal
effects [16] and may magnify care disparities by taking
funds away from safety net hospitals and those with
higher proportions of less advantaged populations [13].
Finally, measuring individual quality measures may not
be a stringent enough measure of care reliability (that is,
are all care processes delivered to all patients who need
them?). This shortcoming of individual process measures
has led some to suggest that process measurement
gives credit only if all measures are met—‘‘all or none’’
measurement [18].
Measuring Outcomes as a Way to Compel Care
Improvements
Outcomes are the truest end result of our care as physicians
and can fall into a number of categories: positive and
negative clinical outcomes, functional status, resource
utilization, satisfaction with care, and health status are
general domains of patient outcome.
There are a number of examples of outcome-driven
healthcare improvement initiatives. Networks such as the
Vermont Oxford Neonatal ICU network [22] and Project
IMPAACT (an ICU collaborative) [7] are notable examples
from nonsurgical specialties.
In surgery, the Veterans’ Affairs (VA) (and now private
sector) National Surgery Quality Improvement Project
(NSQIP) provides a notable model for orthopaedics. The
NSQIP began in the VA in the mid-1990s at the behest of
Congress to address higher surgical mortality in VA hos-
pitals [14]. The VA NSQIP developed an active program of
data collection (initially through paper and later through
electronic sources) of both risk adjustment and outcome
data, which were then used to develop risk adjustment
models and benchmarks for participating VAs. Outlier sites
(those in the lowest 20% of performance) underwent an
audit at a distance; those in the worst 10% of performance
had a site visit from NSQIP leadership. The VA NSQIP
was viewed as highly successful with mortality rates falling
from slightly higher than 3% to lower than 1% in non-
cardiac surgery between 1995 and 2005 [14]. At the end of
their ﬁrst decade, NSQIP investigators found that high-
performing sites shared a number of characteristics,
including focus on standardization, adherence to guide-
lines, and focus on an interdisciplinary approach.
Focus on outcomes requires that adequate risk adjust-
ment can be performed; often this requires collection of
data not available in discharge abstract ﬁles. In addition,
outcomes often have substantial power limitations; in one
study, fewer than 60% of hospitals performed enough
coronary artery bypass surgery in 2 years to provide ade-
quate sample size [3]. However, outcomes have high face
validity and can be tailored to address a clinical practice
speciﬁcally. Often, these outcomes can be chosen so that
sample size issues can be overcome. For example, com-
parisons of functional status in all patients undergoing
arthroplasty would have fewer power limitations than
comparing mortality or need for reoperation.
Discussion
The structure-process-outcome measurement framework
remains a valid starting place for deﬁning areas where care
could be improved, and there are few people who question
its general usefulness in developing a measurement strat-
egy. However, it is clear that stakeholders are increasingly
focusing on initiatives which measure outcomes as the
primary goal and use outcomes to deﬁne structures and
processes which might be changed, rather than compelling
changes in structures or quality measures only. This shift
has been taking place as increasing amounts of evidence
have accumulated to suggest that a multipronged approach
is necessary to improve care through measurement;
improved measurement will be important for surgeons and
payors alike so that clear distinctions between preferred
and non-preferred providers can be made.
It is fairly safe to say that the quality measurement ﬁeld
is not at the beginning of the end, but at the end of the
beginning of its development as a science and management
tool. Increasingly, effective healthcare quality and safety
monitoring systems seek to achieve several goals simulta-
neously: to coordinate effective audit and feedback, deliver
education, reengineer systems, and align goals at the
patient, surgeon, hospital, and payor levels. The ability to
achieve this programmatic goal will be facilitated by
improvements in electronic data systems, which will both
increase the availability of clinically important information
(needed for risk adjustment and deﬁning outcomes) as well
as making data available without the need for costly
manual chart abstraction.
In arthroplasty, there are few randomized-trial based
quality or structural measures that could be applied or
recommended widely; the few that exist target a narrow
spectrum of problems (eg, venous thromboembolism pro-
phylaxis). Lack of a wealth of ‘gold standard’ evidence
describing all aspects of care is not unique to arthroplasty,
and efforts to improve outcomes in orthopaedics will need
to take the more general approach of building infrastructure
necessary to both collect and compare structural, process,
and outcome data effectively.
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comes comparative system in arthroplasty will require
investments in broad based benchmarking (or registry)
projects. Given the long time frame involved in many of the
outcomes of orthopaedic surgery (eg, time to redo-arthro-
plasty, or proportion of prosthetic devices which fail in
10 years), these efforts will need to ﬁnd partners which
allow patients to be tracked over time, as well as across
settings of care. In addition, these systems will need to
include data not commonly collected in administrative data
systems, such as functional status, pain scores, or frequency
of return to work. Next, a robust outcomes-based registry
wouldbemarkedlyenhancedbycollectionofdataregarding
the systems in place at each hospital. Finally, and most
critically, standard and complete reporting of the implants
used will be critical to understanding how and whether care
has been improved. While this is obviously a controversial
point, not knowing a potentially key ‘active ingredient’ to
arthroplasty outcomes seems a glaring deﬁciency; it is
doubtful that we would accept a study comparing outcomes
of a number of preventative agents for thromboembolism
without knowing what the drugs were, yet a similar scenario
is playing out in arthroplasty.
Even the best registry will not change physician
behavior unless it is linked to strong leadership from key
stakeholders, beginning with the patient. This will mean
that attention is paid to the effective dissemination of
effective care practices when they are discovered through
the usual activities of a registry (eg, benchmarking and
outcomes comparison). At least as importantly, there will
need to be attention paid to ineffective or harmful treat-
ments or procedures. A key side effect of the VA portion of
the National Surgical Quality Improvement Program was
that care was localized away from poor-performing sites.
While it is hard to see how sites could be closed or re-
purposed outside of the VA system, efforts which seek to
remediate poor performers through site visits and efforts
from professional societies may be useful.
At least as importantly, leadership in this context does
not imply that leaders somehow become more effective at
getting more pay for services, arguing for wider latitude for
reimbursement or more ﬂexibility in use of relatively
unproven technologies. Rather, leadership in the context of
improving quality and safety will ﬁrst require a focus on
developing generalizable and widely applicable evidence
for the value of deﬁned sets of procedures and implants,
which itself requires better (or any) evidence for the mar-
ginal effectiveness of newer and costlier strategies. Once
evidence is established, leadership in the era of public
accountability will require a focus on standardizing prac-
tices to the extent possible and a relentless drive to
introduce care that is better and more efﬁcient for patients,
not just for physicians. In this context, a traditional focus
on innovation shifts from the biomedical innovations to
healthcare system innovations that improve care while
retaining a clear patient focus. This is the challenge and
opportunity for the 21st century and one that orthopaedics
is very well positioned to adopt.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Birkmeyer JD. High-risk surgery–follow the crowd. JAMA.
2000;283:1191–1193.
2. Birkmeyer JD, Dimick JB. Potential beneﬁts of the new Leapfrog
standards: effect of process and outcomes measures. Surgery.
2004;135:569–575.
3. Birkmeyer JD, Dimick JB, Birkmeyer NJ. Measuring the quality
of surgical care: structure, process, or outcomes? J Am Coll Surg.
2004;198:626–632.
4. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg
DE, Lucas FL. Surgeon volume and operative mortality in the
United States. N Engl J Med. 2003;349:2117–2127.
5. Bradley EH, Herrin J, Elbel B, McNamara RL, Magid DJ,
Nallamothu BK, Wang Y, Normand SL, Spertus JA, Krumholz
HM. Hospital quality for acute myocardial infarction: correlation
among process measures and relationship with short-term mor-
tality. JAMA. 2006;296:72–78.
6. Brooke BS, Perler BA, Dominici F, Makary MA, Pronovost PJ.
Reduction of in-hospital mortality among California hospitals
meeting Leapfrog evidence-based standards for abdominal aortic
aneurysm repair. J Vasc Surg. 2008;47:1155–1156; discussion
1163–1154.
7. Cerner Corporation, Project IMPAACT. Available at: http://
www.cerner.com/piccm/about.html. Accessed March 30, 2009.
8. Christian CK, Gustafson ML, Betensky RA, Daley J, Zinner MJ.
The Leapfrog volume criteria may fall short in identifying high-
quality surgical centers. Ann Surg. 2003;238:447–455; discussion
455–447.
9. Dimick JB, Finlayson SR, Birkmeyer JD. Regional availability of
high-volume hospitals for major surgery. Health Aff (Millwood).
2004;Suppl Web Exclusives:VAR45-53.
10. Donabedian A. Evaluating the quality of medical care. Milbank
Mem Fund Q. 1966;44:Suppl:166–206.
11. Ford EW, Short JC. The impact of health system membership on
patient safety initiatives. Health Care Manage Rev. 2008;33:
13–20.
12. Jha AK, Orav EJ, Ridgway AB, Zheng J, Epstein AM. Does the
Leapfrog program help identify high-quality hospitals? Jt Comm
J Qual Patient Saf. 2008;34:318–325.
13. Karve AM, Ou FS, Lytle BL, Peterson ED. Potential unintended
ﬁnancial consequences of pay-for-performance on the quality of
care for minority patients. Am Heart J. 2008;155:571–576.
14. Khuri SF. Safety, quality, and the National Surgical Quality
Improvement Program. Am Surg. 2006;72:994–998; discussion
1021–1030, 1133–1048.
15. Khuri SF, Henderson WG. The case against volume as a measure
of quality of surgical care. World J Surg. 2005;29:1222–1229.
16. Lindenauer PK, Remus D, Roman S, Rothberg MB, Benjamin
EM, Ma A, Bratzler DW. Public reporting and pay for perfor-
mance in hospital quality improvement. N Engl J Med. 2007;356:
486–496.
2546 Auerbach Clinical Orthopaedics and Related Research
12317. Mehta RH, Liang L, Karve AM, Hernandez AF, Rumsfeld JS,
Fonarow GC, Peterson ED. Association of patient case-mix
adjustment, hospital process performance rankings, and eligibility
for ﬁnancial incentives. JAMA. 2008;300:1897–1903.
18. Nolan T, Berwick DM. All-or-none measurement raises the bar
on performance. JAMA. 2006;295:1168–1170.
19. Peterson ED, Coombs LP, DeLong ER, Haan CK, Ferguson TB.
Procedural volume as a marker of quality for CABG surgery.
JAMA. 2004;291:195–201.
20. Ricciardi R, Virnig BA, Ogilvie JW, Jr, Dahlberg PS, Selker HP,
Baxter NN. Volume-outcome relationship for coronary artery
bypass grafting in an era of decreasing volume. Arch Surg.
2008;143:338–344; discussion 344.
21. Surgical Care Improvement Program. Available at: http://www.
medqic.org/dcs/ContentServer?cid=1122904930422&pagename=
Medqic%2FContent%2FParentShellTemplate&parentName=
Topic&c=MQParents. Accessed March 29, 2009.
22. Vermont Oxford Collaborative. Available at: http://www.
vtoxford.org/. Accessed March 29, 2009.
23. Vollmer CM, Jr, Pratt W, Vanounou T, Maithel SK, Callery MP.
Quality assessment in high-acuity surgery: volume and mortality
are not enough. Arch Surg. 2007;142:371–380.
24. Ward MM, Jaana M, Wakeﬁeld DS, Ohsfeldt RL, Schneider JE,
Miller T, Lei Y. What would be the effect of referral to high-
volume hospitals in a largely rural state? J Rural Health.
2004;20:344–354.
Volume 467, Number 10, October 2009 Quality Measurement in Orthopaedic Surgery 2547
123